Cargando…
2461. Carbapenem-resistant Enterobacterales reported to the National Healthcare Safety Network Multidrug-Resistant Organism & Clostridioides difficile Infection Module, January 2018 to July 2022
BACKGROUND: To describe the COVID-19 pandemic’s impact on the spread of multidrug-resistant organisms, we compared pre-pandemic and pandemic laboratory-identified carbapenem-resistant Enterobacterales (CRE) events reported to the National Healthcare Safety Network (NHSN). [Figure: see text] METHODS:...
Autores principales: | Cincotta, Samuel E, Octaria, Rany, Maroya, Walters |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678992/ http://dx.doi.org/10.1093/ofid/ofad500.2079 |
Ejemplares similares
-
An interactive patient transfer network and model visualization tool for multidrug-resistant organism prevention strategies
por: Octaria, Rany, et al.
Publicado: (2023) -
Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection
por: Lee, Ching-Chi, et al.
Publicado: (2022) -
Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
por: Cincotta, Samuel, et al.
Publicado: (2022) -
Clinical Outcomes Associated with Co-infection of Carbapenem-Resistant Enterobacterales and other Multidrug-Resistant Organisms
por: Tadese, Bekana K., et al.
Publicado: (2022) -
Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates
por: Shortridge, Dee, et al.
Publicado: (2023)